Kelman Lazarov Inc. increased its stake in GMO U.S. Quality ETF (NYSEARCA:QLTY – Free Report) by 4.0% in the 1st quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 380,573 shares of the company’s stock after acquiring an additional 14,716 shares during the quarter. GMO U.S. Quality ETF makes up about 2.0% of Kelman Lazarov Inc.’s portfolio, making the stock its 18th biggest holding. Kelman Lazarov Inc.’s holdings in GMO U.S. Quality ETF were worth $13,769,000 as of its most recent filing with the SEC.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in the stock. Breakwater Capital Group lifted its holdings in GMO U.S. Quality ETF by 89.8% during the first quarter. Breakwater Capital Group now owns 24,449 shares of the company’s stock valued at $885,000 after purchasing an additional 11,568 shares in the last quarter. Aspen Investment Management Inc increased its stake in shares of GMO U.S. Quality ETF by 4.6% during the first quarter. Aspen Investment Management Inc now owns 27,800 shares of the company’s stock worth $1,006,000 after purchasing an additional 1,210 shares in the last quarter. Sprinkle Financial Consultants LLC raised its position in shares of GMO U.S. Quality ETF by 10.5% during the 1st quarter. Sprinkle Financial Consultants LLC now owns 87,268 shares of the company’s stock worth $3,157,000 after purchasing an additional 8,264 shares during the last quarter. Triangle Securities Wealth Management lifted its stake in GMO U.S. Quality ETF by 3.5% in the 1st quarter. Triangle Securities Wealth Management now owns 121,885 shares of the company’s stock valued at $4,410,000 after buying an additional 4,155 shares in the last quarter. Finally, Vicus Capital lifted its stake in GMO U.S. Quality ETF by 436.9% in the 1st quarter. Vicus Capital now owns 139,323 shares of the company’s stock valued at $5,041,000 after buying an additional 113,375 shares in the last quarter. Hedge funds and other institutional investors own 85.37% of the company’s stock.
GMO U.S. Quality ETF Stock Performance
QLTY stock opened at $41.70 on Friday. GMO U.S. Quality ETF has a 12-month low of $33.56 and a 12-month high of $41.95. The stock has a market cap of $4.70 billion, a price-to-earnings ratio of 57.92 and a beta of 0.97. The business’s 50-day moving average is $40.78 and its 200 day moving average is $39.22.
GMO U.S. Quality ETF Company Profile
The GMO U.S. Quality ETF (QLTY) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund that focuses on equities of high-quality US companies. The funds investments may include companies of any market capitalization. QLTY was launched on Nov 13, 2023 and is issued by GMO.
Featured Articles
- Five stocks we like better than GMO U.S. Quality ETF
- AST SpaceMobile’s Japan Catalyst Puts Its Rollout Story Back in Focus
- Gold and Silver Recovery—3 Precious Metals Stocks for H2 2026
- Klarna’s Google Court Win Could Give Its BNPL Story a Needed Cash Catalyst
- Why Kroger’s Giant Eagle Deal Could Change Everything
Want to see what other hedge funds are holding QLTY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for GMO U.S. Quality ETF (NYSEARCA:QLTY – Free Report).
Receive News & Ratings for GMO U.S. Quality ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GMO U.S. Quality ETF and related companies with MarketBeat.com's FREE daily email newsletter.
